Analysts Offer Insights on Healthcare Companies: Catalent (NYSE: CTLT) and Amgen Inc (NASDAQ: AMGN)

By Carrie Williams

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalent (NYSE: CTLT) and Amgen Inc (NASDAQ: AMGN).

Catalent (NYSE: CTLT)

Jefferies analyst David Windley reiterated a Hold rating on Catalent (NYSE: CTLT) yesterday and set a price target of $38. The company’s shares closed yesterday at $35.36.

According to TipRanks.com, Windley is a top 25 analyst with an average return of 20.0% and a 79.0% success rate. Windley covers the Services sector, focusing on stocks such as Quintiles Transnational, Quest Diagnostics Inc, and WellCare Health Plans.

Catalent has an analyst consensus of Moderate Buy, with a price target consensus of $39.

Amgen Inc (NASDAQ: AMGN)

In a report issued on August 27, Michael Yee from Jefferies reiterated a Buy rating on Amgen Inc (NASDAQ: AMGN), with a price target of $200. The company’s shares closed yesterday at $171.78.

According to TipRanks.com, Yee is a 4-star analyst with an average return of 8.1% and a 55.4% success rate. Yee covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Arbutus Biopharma Corporation, and Proteostasis Therapeutics Inc.

Currently, the analyst consensus on Amgen Inc is Moderate Buy and the average price target is $186, representing an 8.3% upside.

In a report issued on August 16, Oppenheimer also reiterated a Buy rating on the stock with a $203 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.